Come up with a name for your new list and we'll add to it:
ActivBiotics raised a round of funding on , . Investors include
New England Partners.
ActivBiotics is focused on the development and commercialization of antibacterials for the treatment of acute and chronic disease. The Company is developing rifalazil - a potent broad spectrum antibio…